BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26572989)

  • 1. Nuclear grade plus proliferation grading system for invasive ductal carcinoma of the breast: validation in a tertiary referral hospital cohort.
    Papadimitriou M; Kaptanis S; Polymeropoulos E; Mitsopoulos G; Stogiannis D; Caroni C; Vaiopoulos G; Panayiotides JG; Karakitsos P
    Am J Clin Pathol; 2015 Dec; 144(6):837-43. PubMed ID: 26572989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count.
    Tawfik O; Kimler BF; Davis M; Stasik C; Lai SM; Mayo MS; Fan F; Donahue JK; Damjanov I; Thomas P; Connor C; Jewell WR; Smith H; Fabian CJ
    Virchows Arch; 2007 Jun; 450(6):627-36. PubMed ID: 17458558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A newly proposed semi-automated method of grading invasive lobular carcinoma: a unifying concept and correlation with prognostic markers and patient survival.
    Stevens E; Kimler BF; Davis MK; Fan F; Thomas P; Wang XY; Damjanov I; Tawfik OW
    Ann Clin Lab Sci; 2009; 39(1):25-31. PubMed ID: 19201737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
    Sinha PS; Bendall S; Bates T
    Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of the Nottingham Histological Grading Parameters and Nottingham Prognostic Index in Canine Mammary Carcinoma.
    Santos M; Correia-Gomes C; Marcos R; Santos A; De Matos A; Lopes C; Dias-Pereira P
    Anticancer Res; 2015 Jul; 35(7):4219-27. PubMed ID: 26124382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vimentin in breast carcinoma, its correlation with Ki67 and other histopathological parameters.
    Hemalatha A; Suresh TN; Kumar ML
    Indian J Cancer; 2013; 50(3):189-94. PubMed ID: 24061457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
    Falco M
    Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
    Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M
    Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grading system for blood vessel tumor emboli of invasive ductal carcinoma of the breast.
    Sugiyama M; Hasebe T; Shimada H; Takeuchi H; Shimizu K; Shimizu M; Yasuda M; Ueda S; Shigekawa T; Osaki A; Saeki T
    Hum Pathol; 2015 Jun; 46(6):906-16. PubMed ID: 25890786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic grading of invasive lobular carcinoma: does use of a 2-tiered nuclear grading system improve interobserver variability?
    Adams AL; Chhieng DC; Bell WC; Winokur T; Hameed O
    Ann Diagn Pathol; 2009 Aug; 13(4):223-5. PubMed ID: 19608079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of bcl-2, c-myc, survivin and tumor grade in synovial sarcoma.
    Demır D; Yaman B; Anacak Y; Keçecı B; Kandıloğlu G; Akalin T
    Turk Patoloji Derg; 2014; 30(1):55-65. PubMed ID: 24448706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
    Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
    Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
    Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
    J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BGX-Ki-67 index as a supplementary marker to MIB-1 index, enabling more precise distinction between luminal A and B subtypes of breast carcinoma and eliminating the problem of membranous/cytoplasmic MIB-1 staining.
    Niemiec J; Adamczyk A; Ambicka A; Mucha-Małecka A; Wysocki WM; Majchrzyk K; Ryś J
    Am J Clin Pathol; 2015 Mar; 143(3):419-29. PubMed ID: 25696801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast.
    Hasebe T; Okada N; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Tsuda H; Kinoshita T
    Hum Pathol; 2010 May; 41(5):706-15. PubMed ID: 20060154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 in invasive breast carcinoma: favourable prognostic significance in unselected patients and within subgroups with an aggressive phenotype.
    Mylona E; Tzelepis K; Theohari I; Giannopoulou I; Papadimitriou C; Nakopoulou L
    Histopathology; 2013 Feb; 62(3):472-80. PubMed ID: 23163571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
    Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
    Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOXB9 expression promoting tumor cell proliferation and angiogenesis is associated with clinical outcomes in breast cancer patients.
    Seki H; Hayashida T; Jinno H; Hirose S; Sakata M; Takahashi M; Maheswaran S; Mukai M; Kitagawa Y
    Ann Surg Oncol; 2012 Jun; 19(6):1831-40. PubMed ID: 22396001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.